Eligibility for hormonal therapies depends on the presence of hormone receptors in the cancer cells. Tests like the Estrogen Receptor (ER) Test and Progesterone Receptor (PR) Test help determine if a cancer is hormone receptor-positive and therefore likely to respond to hormonal therapy.
